Author
Listed:
- Uğur Şahin
(BioNTech
TRON gGmbH – Translational Oncology at the University Medical Center of the Johannes Gutenberg University)
- Alexander Muik
(BioNTech)
- Isabel Vogler
(BioNTech)
- Evelyna Derhovanessian
(BioNTech)
- Lena M. Kranz
(BioNTech)
- Mathias Vormehr
(BioNTech)
- Jasmin Quandt
(BioNTech)
- Nicole Bidmon
(BioNTech)
- Alexander Ulges
(BioNTech)
- Alina Baum
(Regeneron Pharmaceuticals, Inc.)
- Kristen E. Pascal
(Regeneron Pharmaceuticals, Inc.)
- Daniel Maurus
(BioNTech)
- Sebastian Brachtendorf
(BioNTech)
- Verena Lörks
(BioNTech)
- Julian Sikorski
(BioNTech)
- Peter Koch
(BioNTech)
- Rolf Hilker
(BioNTech)
- Dirk Becker
(BioNTech)
- Ann-Kathrin Eller
(BioNTech)
- Jan Grützner
(BioNTech)
- Manuel Tonigold
(BioNTech)
- Carsten Boesler
(BioNTech)
- Corinna Rosenbaum
(BioNTech)
- Ludwig Heesen
(BioNTech)
- Marie-Cristine Kühnle
(BioNTech)
- Asaf Poran
(BioNTech US)
- Jesse Z. Dong
(BioNTech US)
- Ulrich Luxemburger
(BioNTech)
- Alexandra Kemmer-Brück
(BioNTech)
- David Langer
(BioNTech)
- Martin Bexon
(Bexon Clinical Consulting LLC)
- Stefanie Bolte
(BioNTech)
- Tania Palanche
(BioNTech)
- Armin Schultz
(CRS Clinical Research Services Mannheim GmbH)
- Sybille Baumann
(CRS Clinical Research Services Berlin GmbH)
- Azita J. Mahiny
(BioNTech)
- Gábor Boros
(BioNTech)
- Jonas Reinholz
(BioNTech)
- Gábor T. Szabó
(BioNTech)
- Katalin Karikó
(BioNTech)
- Pei-Yong Shi
(University of Texas Medical Branch)
- Camila Fontes-Garfias
(University of Texas Medical Branch)
- John L. Perez
(Pfizer)
- Mark Cutler
(Pfizer)
- David Cooper
(Pfizer)
- Christos A. Kyratsous
(Regeneron Pharmaceuticals, Inc.)
- Philip R. Dormitzer
(Pfizer)
- Kathrin U. Jansen
(Pfizer)
- Özlem Türeci
(BioNTech)
Abstract
No abstract is available for this item.
Suggested Citation
Uğur Şahin & Alexander Muik & Isabel Vogler & Evelyna Derhovanessian & Lena M. Kranz & Mathias Vormehr & Jasmin Quandt & Nicole Bidmon & Alexander Ulges & Alina Baum & Kristen E. Pascal & Daniel Mauru, 2025.
"Author Correction: BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans,"
Nature, Nature, vol. 643(8074), pages 27-27, July.
Handle:
RePEc:nat:nature:v:643:y:2025:i:8074:d:10.1038_s41586-025-09355-7
DOI: 10.1038/s41586-025-09355-7
Download full text from publisher
As the access to this document is restricted, you may want to
for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:643:y:2025:i:8074:d:10.1038_s41586-025-09355-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.